Cargando…

Predicting unfavorable long-term outcome in juvenile idiopathic arthritis: results from the Nordic cohort study

BACKGROUND: The aim was to develop prediction rules that may guide early treatment decisions based on baseline clinical predictors of long-term unfavorable outcome in juvenile idiopathic arthritis (JIA). METHODS: In the Nordic JIA cohort, we assessed baseline disease characteristics as predictors of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rypdal, Veronika, Arnstad, Ellen Dalen, Aalto, Kristiina, Berntson, Lillemor, Ekelund, Maria, Fasth, Anders, Glerup, Mia, Herlin, Troels, Nielsen, Susan, Peltoniemi, Suvi, Zak, Marek, Rygg, Marite, Rypdal, Martin, Nordal, Ellen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5934822/ https://www.ncbi.nlm.nih.gov/pubmed/29724248 http://dx.doi.org/10.1186/s13075-018-1571-6

Ejemplares similares

Complement lectin pathway protein levels reflect disease activity in juvenile idiopathic arthritis: a longitudinal study of the Nordic JIA cohort
por: Glerup, Mia, et al.
Publicado: (2019)

Participation in school and physical education in juvenile idiopathic arthritis in a Nordic long-term cohort study
por: Nordal, Ellen, et al.
Publicado: (2019)

Fatigue in young adults with juvenile idiopathic arthritis 18 years after disease onset: data from the prospective Nordic JIA cohort
por: Arnstad, Ellen Dalen, et al.
Publicado: (2021)

Transitioning patients with juvenile idiopathic arthritis to adult care: the Nordic experience
por: Mikola, Katriina, et al.
Publicado: (2022)

Validation of prediction models of severe disease course and non-achievement of remission in juvenile idiopathic arthritis: part 1—results of the Canadian model in the Nordic cohort
por: Rypdal, Veronika, et al.
Publicado: (2019)

Incidence and predictors of Uveitis in juvenile idiopathic arthritis in a Nordic long-term cohort study
por: Nordal, Ellen, et al.
Publicado: (2017)

Prognostic factors for the disease course and 8-year outcome in Nordic children with oligoarticular-onset juvenile idiopathic arthritis
por: Peltoniemi, Suvi, et al.
Publicado: (2014)

Ongoing disease-activity and change in ILAR categories in a Nordic juvenile idiopathic arthritis cohort
por: Nordal, Ellen, et al.
Publicado: (2012)

Psoriasis and associated variables in classification and outcome of juvenile idiopathic arthritis - an eight-year follow-up study
por: Ekelund, Maria, et al.
Publicado: (2017)

Histone antibodies as a biomarker of uveitis in JIA
por: Nordal, Ellen B, et al.
Publicado: (2014)

Juvenile arthritis disease activity score (JADAS) based on C-reactive protein predicts DMARD treatment in juvenile idiopathic arthritis in a Nordic multicenter cohort
por: Nordal, Ellen, et al.
Publicado: (2012)

Anti-type II collagen antibodies, anti-CCP, IgA RF and IgM RF are associated with joint damage, assessed eight years after onset of juvenile idiopathic arthritis (JIA)
por: Berntson, Lillemor, et al.
Publicado: (2014)

Ankle arthritis predicts worse outcome in children with juvenile idiopathic arthritis
por: Esbjörnsson, Anna-Clara, et al.
Publicado: (2014)

PReS-FINAL-2046: Uveitis in the Nordic juvenile idiopathic arthritis cohort; high incidence, frequent complications, and gender-associated risk factors
por: Nordal, EB, et al.
Publicado: (2013)

Juvenile Arthritis Disease Activity Score (JADAS) based on CRP; validity and predictive ability in a Nordic population-based setting
por: Nordal, EB, et al.
Publicado: (2011)

M-ficolin: a valuable biomarker to identify leukaemia from juvenile idiopathic arthritis
por: Brix, Ninna, et al.
Publicado: (2022)

Validation of prediction models of severe disease course and non-achievement of remission in juvenile idiopathic arthritis part 2: results of the Nordic model in the Canadian cohort
por: Henrey, Andrew, et al.
Publicado: (2020)

Non-HLA genepolymorphisms in juvenile chronic arthritis: associations with outcome of disease
por: Alberdi-Saugstrup, Mikel, et al.
Publicado: (2014)

PReS-FINAL-2071: Anti-type II collagen antibodies, anti-CCP, IgA-RF and IgM-RF are associated with joint damage eight years after onset of juvenile idiopathic arthritis (JIA)
por: Berntson, L, et al.
Publicado: (2013)

A novel serum calprotectin (MRP8/14) particle-enhanced immuno-turbidimetric assay (sCAL turbo) helps to differentiate systemic juvenile idiopathic arthritis from other diseases in routine clinical laboratory settings
por: Foell, Dirk, et al.
Publicado: (2023)

Pain sensitivity in young adults with juvenile idiopathic arthritis: a quantitative sensory testing study
por: Arnstad, Ellen Dalen, et al.
Publicado: (2020)

HLA-B27 predicts a more extended disease with increasing age at onset in boys with juvenile idiopathic arthritis
por: Berntson, L, et al.
Publicado: (2008)

Neurophysiologic pain response in patients with juvenlie idiopathic arthritis - a pilot study
por: Iversen, Johanne Marie M, et al.
Publicado: (2014)

Disease characteristics of HLA-B27 positive and negative finnish patients with juvenile idiopathic arthritis - results of the 18-year cohort follow-up study
por: Peltoniemi, Suvi Oili Orvokki, et al.
Publicado: (2023)

Oral health-related quality of life, impaired physical health and orofacial pain in children and adolescents with juvenile idiopathic arthritis – a prospective multicenter cohort study
por: Halbig, Josefine M., et al.
Publicado: (2023)

Modelling suggests limited change in the reproduction number from reopening Norwegian kindergartens and schools during the COVID-19 pandemic
por: Rypdal, Martin, et al.
Publicado: (2021)

A Parsimonious Description and Cross-Country Analysis of COVID-19 Epidemic Curves
por: Rypdal, Kristoffer, et al.
Publicado: (2020)

May antihistone antibodies replace antinuclear antibodies (ANA) as a predictor of uveitis in Juvenile idiopathic arthritis?
por: Nordal, EB, et al.
Publicado: (2008)

Intervention Fatigue is the Primary Cause of Strong Secondary Waves in the COVID-19 Pandemic
por: Rypdal, Kristoffer, et al.
Publicado: (2020)

Effect of infliximab in sweet’s syndrome-pyoderma gangraenosum overlap syndrome
por: Mahler, Birgitte, et al.
Publicado: (2014)

Biologic switching patterns among children with non-systemic juvenile idiopathic arthritis
por: Pedersen, Mia Lindegaard, et al.
Publicado: (2023)

The Tipping Effect of Delayed Interventions on the Evolution of COVID-19 Incidence
por: Rypdal, Kristoffer
Publicado: (2021)

Generalized pustular psoriasis in infant with heterozygous mutation in the IL36RN gene successfully treated with infliximab
por: Glerup, Mia, et al.
Publicado: (2014)

Identifying acute lymphoblastic leukemia mimicking juvenile idiopathic arthritis in children
por: Brix, Ninna, et al.
Publicado: (2020)

The Danish version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR)
por: Nielsen, Susan, et al.
Publicado: (2018)

Evaluation of Macrophage Activation Syndrome in Patients with Systemic Juvenile Idiopathic Arthritis: A Single Center Experience
por: Høeg, Pia Elkjær, et al.
Publicado: (2022)

Inter-outbreak stability reflects the size of the susceptible pool and forecasts magnitudes of seasonal epidemics
por: Rypdal, Martin, et al.
Publicado: (2019)

Estimation of Excess Mortality and Years of Life Lost to COVID-19 in Norway and Sweden between March and November 2020
por: Rypdal, Martin, et al.
Publicado: (2021)

The Swedish version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR)
por: Ekelund, Maria, et al.
Publicado: (2018)

Efficacy and safety of intraarticular corticosteroid injections in adolescents with juvenile idiopathic arthritis in the temporomandibular joint: a Norwegian 2-year prospective multicenter pilot study
por: Frid, Paula, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_3j3k18513rt1h21o2qod3bqd9n